CN113727737A - 肿瘤细胞外基质中癌蛋白特异性肽pet/spect探针 - Google Patents

肿瘤细胞外基质中癌蛋白特异性肽pet/spect探针 Download PDF

Info

Publication number
CN113727737A
CN113727737A CN202080021838.2A CN202080021838A CN113727737A CN 113727737 A CN113727737 A CN 113727737A CN 202080021838 A CN202080021838 A CN 202080021838A CN 113727737 A CN113727737 A CN 113727737A
Authority
CN
China
Prior art keywords
seq
linker
cancer
derivatives
pet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080021838.2A
Other languages
English (en)
Chinese (zh)
Inventor
Z-R·卢
S·高
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Case Western Reserve University
Original Assignee
Case Western Reserve University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Case Western Reserve University filed Critical Case Western Reserve University
Publication of CN113727737A publication Critical patent/CN113727737A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Nuclear Medicine (AREA)
  • Medicinal Preparation (AREA)
CN202080021838.2A 2019-01-17 2020-01-17 肿瘤细胞外基质中癌蛋白特异性肽pet/spect探针 Pending CN113727737A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962793789P 2019-01-17 2019-01-17
US62/793,789 2019-01-17
PCT/US2020/014110 WO2020150617A2 (en) 2019-01-17 2020-01-17 Peptide pet/spect probes specific to oncoproteins in tumor extracellula matrix

Publications (1)

Publication Number Publication Date
CN113727737A true CN113727737A (zh) 2021-11-30

Family

ID=71614081

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080021838.2A Pending CN113727737A (zh) 2019-01-17 2020-01-17 肿瘤细胞外基质中癌蛋白特异性肽pet/spect探针

Country Status (8)

Country Link
US (1) US12576168B2 (https=)
EP (1) EP3911373A4 (https=)
JP (2) JP7702871B2 (https=)
KR (1) KR20210115003A (https=)
CN (1) CN113727737A (https=)
AU (1) AU2020208492B2 (https=)
CA (1) CA3127188A1 (https=)
WO (1) WO2020150617A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024183417A1 (zh) * 2023-03-08 2024-09-12 中国科学院深圳先进技术研究院 一种靶向肿瘤的超声造影剂及其制备方法和应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574280B (zh) * 2020-12-21 2022-05-17 北京大学第一医院 一种双酶体系探针及其应用
US20240252662A1 (en) * 2021-05-20 2024-08-01 Case Western Reserve University Peptide drug conjugates specific to fibronectin isotypes for cancer therapy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120244070A1 (en) * 2011-03-25 2012-09-27 Case Western Reserve University Fibronectin targeting contrast agent
WO2013106824A1 (en) * 2012-01-13 2013-07-18 Board Of Regents, The University Of Texas System Epherin receptor targeting agents
CN107001417A (zh) * 2014-08-04 2017-08-01 卡斯西部储备大学 靶向肽及其使用方法
US20180110886A1 (en) * 2014-08-04 2018-04-26 Case Western Reserve University Molecular probes and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3060143A1 (en) 2017-05-24 2018-11-29 Itm Isotopen Technologien Munchen Ag Novel psma-binding agents and uses thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120244070A1 (en) * 2011-03-25 2012-09-27 Case Western Reserve University Fibronectin targeting contrast agent
WO2013106824A1 (en) * 2012-01-13 2013-07-18 Board Of Regents, The University Of Texas System Epherin receptor targeting agents
CN107001417A (zh) * 2014-08-04 2017-08-01 卡斯西部储备大学 靶向肽及其使用方法
US20170224848A1 (en) * 2014-08-04 2017-08-10 Case Western Reserve University Targeting peptides and methods of use
US20180110886A1 (en) * 2014-08-04 2018-04-26 Case Western Reserve University Molecular probes and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHENG HAN等: "Preparation and Evaluation of ZD2 Peptide 64Cu-DOTA Conjugate as a Positron Emission Tomography Probe for Detection and Characterization of Prostate Cancer" *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024183417A1 (zh) * 2023-03-08 2024-09-12 中国科学院深圳先进技术研究院 一种靶向肿瘤的超声造影剂及其制备方法和应用

Also Published As

Publication number Publication date
EP3911373A2 (en) 2021-11-24
JP2025063147A (ja) 2025-04-15
CA3127188A1 (en) 2020-07-23
AU2020208492A1 (en) 2021-08-12
US12576168B2 (en) 2026-03-17
JP2022517662A (ja) 2022-03-09
WO2020150617A8 (en) 2021-02-18
WO2020150617A2 (en) 2020-07-23
JP7702871B2 (ja) 2025-07-04
KR20210115003A (ko) 2021-09-24
US20220160903A1 (en) 2022-05-26
EP3911373A4 (en) 2023-01-25
AU2020208492B2 (en) 2026-04-02

Similar Documents

Publication Publication Date Title
US11766414B2 (en) Compositions, delivery systems, and methods useful in tumor therapy
US10653801B2 (en) Targeting peptides and methods of use
JP5676673B2 (ja) 癌の画像化および処置
Tanaka et al. PET (positron emission tomography) imaging of biomolecules using metal–DOTA complexes: A new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics
US12599684B2 (en) Molecular probes and methods of use
US20100202967A1 (en) Fibrin binding pepetide conjugates for diagnostic and therapeutic applications
JP2025063147A (ja) 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドｐｅｔ／ｓｐｅｃｔプローブ
JP6979180B2 (ja) 診断及び治療のための、改善された薬物動態及びコレシストキニン−２受容体（ｃｃｋ２ｒ）への標的化
US20240053349A1 (en) Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
KR20040055784A (ko) 종양의 영상 및 치료용 피에이씨에이피 조성물 및 방법
US20240325574A1 (en) Extradomain b fibronectin targeting peptides and derivatives for cancer imaging and therapy
CN114845742A (zh) 用于癌症成像和治疗的经改性的grpr拮抗剂肽
WO2025061971A1 (en) Functionalized peptides for in-vivo addressing of pd-l1 expression
WO2024046469A1 (zh) 环肽及其制备方法、包括其的复合物、及其用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination